The Second Chance at Life Act of 2025 requires abortion providers to inform women seeking chemical abortions (using mifepristone and misoprostol) that the effects may be reversible if they change their mind, with this notification required at least 24 hours before the procedure. The bill mandates that providers give written discharge instructions after dispensing the first drug, post conspicuous signage in waiting and consultation rooms, and direct patients to information on a new Department of Health and Human Services website about abortion reversal options. The bill takes effect 30 days after enactment and includes a medical emergency exception, as well as civil remedies allowing women, fathers, and parents to sue providers for violations and recover attorney's fees. The legislation does not prevent states from implementing more stringent disclosure requirements than those specified in the federal law.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.